RORA and Parkinson disease: Additionally, we adopted a dopaminergic cell culture model of PD in order to investigate directly the potential neuroprotective effects of RORA and its underlying mechanisms, taking advantage of the recently characterised pharmacological tools of the RORα/γ agonist (SR1078) and antagonist (SR1001)36.